Total
0
Shares
Amplia Therapeutics - CEO and MD, Dr John Lambert
CEO and MD, Dr John Lambert
Source: Amplia Therapeutics
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Amplia Therapeutics (ATX) has been granted a $2.1 million Research and Development (R&D) cash flow loan
  • The $2.1 million will be awarded in two tranches: $1.3m in December this year and $0.8 million in the quarter ending March 31, 2022
  • The company says it will use funds to increase work on its second Focal Adhesion Kinase (FAK) inhibitor, AMP886
  • This will allow Amplia to evaluate new therapeutic opportunities and prepare preclinical activates designed to support future clinical trials of AMP886
  • Amplia Therapeutics is up 2.9 per cent, trading at 18 cents at 12:40 pm AEDT

Amplia Therapeutics (ATX) has been granted a $2.1 million Research and Development (R&D) cash flow loan.

The company’s non-dilutive funding facility forms part of the Victorian government’s R&D Cash Flow Initiative.

The $2.1 million will be awarded in two tranches: $1.3m in December this year and $0.8 million in the quarter ending March 31, 2022.

The facility relates to FY2022 R&D expenditure and is in addition to R&D rebate received for the FY2021 period.

The company says it will use funds to increase work on its second Focal Adhesion Kinase (FAK) inhibitor, AMP886.

This will allow Amplia to evaluate new therapeutic opportunities and prepare preclinical activates designed to support future clinical trials of AMP886.

Amplia’s CEO and managing director, Dr John Lambert, said further studies evaluating the antifibrotic potential of AMP945 is also in the works.

“The first Phase 2 clinical study of our leading FAK inhibitor AMP945 is funded and about to commence,” he said.

“This loan allows us to kick-start work on a second asset, AMP886, earlier and more aggressively than originally planned. We are very grateful to Invest Victoria for their support.”

Amplia Therapeutics is up 2.9 per cent, trading at 18 cents at 12:40 pm AEDT.  

ATX by the numbers
More From The Market Herald
EVZ (ASX:EVZ) - CEO, Scott Farthing

" EVZ’s (ASX:EVZ) Brockman Engineering secures LOI for $40m storage tanks project

EVZ’s (ASX:EVZ) wholly-owned subsidiary Brockman Engineering has secured a Letter of Intent (LOI) from Viva Energy.

" Kin Mining (ASX:KIN) enters into earn-in and joint venture agreement with Golden Mile Resources (ASX:G88)

Kin Mining (ASX:KIN) enters into earn-in and joint venture agreement with Golden Mile Resources (ASX:G88).

" AIC Mines (ASX:A1M) applies for new tenements in NSW

AIC Mines (ASX:A1M) has applied for two exploration licences in western New South Wales that are…

" African Gold (ASX:A1G) launches diamond drilling program at Didievi

Junior explorer African Gold (ASX:A1G) has kicked off a drilling program across some key prospects at…